Clinical characteristics and validation of bronchiectasis severity score systems for post‐tuberculosis bronchiectasis

Wang, Hong; Ji, Xiao-Bin; Li, Chengwei; Lu, Hai‐Wen; Mao, Baohua; Liang, Shuo; Cheng, Kebin; Bai, Jing; Martínez-García, Miguel Ángel; Xu, Jin

doi:10.1111/crj.12911

Cited by 19 publications

(23 citation statements)

References 20 publications

(41 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Previous studies of the BSI and FACED scores have been conducted in Europeans with bronchiectasis from different backgrounds, but these scoring systems have also been proven to be useful predictors of prognosis in Asians. 32 , 33 …”

Section: Discussionmentioning

confidence: 99%

Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis

Jeong

Heo

et al. 2021

Chron Respir Dis

View full text Add to dashboard Cite

We evaluated serum albumin as an index for predicting respiratory hospitalization in patients with bronchiectasis. We retrospectively reviewed the medical records of 177 patients with bronchiectasis, categorized them into low and normal albumin groups, and compared their clinical characteristics. The prediction of respiratory hospitalization by factors such as serum albumin level, bronchiectasis severity index (BSI), and FACED score (an acronym derived from five variables of forced expiratory volume in 1 s; FEV1, age, chronic colonization of Pseudomonas aeruginosa, extent of bronchiectasis, and dyspnea) was assessed. There were 15 and 162 patients categorized in the low and normal albumin groups, respectively. The low albumin group had lower body mass index and forced expiratory volume in 1 s, and higher age, frequency of previous respiratory hospitalization, percentage of Pseudomonas colonization, number of affected lobes, BSI and FACED scores, and C-reactive protein (CRP) level, than the normal albumin group. The areas under the receiver operating characteristic curve of serum albumin level and BSI and FACED scores for predicting respiratory hospitalization were 0.732 (95% confidence interval (CI), 0.647–0.816), 0.873 (95% CI, 0.817–0.928), and 0.708 (95% CI, 0.618–0.799), respectively. Albumin level, CRP, modified Medical Research Council score, and chronic Pseudomonas aeruginosa (and other organisms) colonization were independent risk factors for respiratory hospitalization. Low serum albumin level was associated with worse clinical condition, higher severity scores, and respiratory hospitalization in patients with bronchiectasis.

show abstract

Section: Discussionmentioning

confidence: 99%

Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis

Jeong

Heo

et al. 2021

Chron Respir Dis

View full text Add to dashboard Cite

show abstract

“…Non-tuberculous mycobacterial lung disease also presents higher percentages than Western countries (nearly 5%); 24 h gastroesophageal pH monitoring would benefit patients with gastroesophageal reflux-related bronchiectasis. [ 3 7 8 ] Studies have shown that rheumatoid arthritis, chronic obstructive pulmonary disease, asthma, and chronic rhinosinusitis are associated with bronchiectasis. [ 9 10 11 12 ] Thus, attention should be paid to these factors to detect bronchiectasis in its initial stages and utilize optimization of patient care in China.…”

Section: P Ay M Ore a mentioning

confidence: 99%

Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines

Wang

2018

Chinese Medical Journal

Self Cite

View full text Add to dashboard Cite

“…Patients with post-TB bronchiectasis typically show airflow obstruction in addition to recurrent episodes of purulent sputum production and haemoptysis [ 9 , 10 ]. Although two studies assessed the performance of bronchiectasis severity scoring systems in post-TB bronchiectasis [ 11 , 12 ], there is limited information on the clinical characteristics of post-TB bronchiectasis in the context of a bronchiectasis cohort.…”

Section: Introductionmentioning

confidence: 99%

Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry

Choi

Lee

Won

et al. 2021

JCM

View full text Add to dashboard Cite

The clinical characteristics of patients with post-tuberculosis (TB) bronchiectasis have not been well evaluated. We enrolled 598 patients with bronchiectasis who participated in the Korean prospective bronchiectasis registry and compared the characteristics of post-TB bronchiectasis (19.7%) with post-infectious (19.6%), idiopathic (40.8%), and other (19.9%) bronchiectasis. The patients with post-TB bronchiectasis had a lower body mass index, higher rate of chronic obstructive pulmonary disease, and lower rate of asthma than those in the other groups. The patients with post-TB bronchiectasis had more upper lobe involvement, more severe radiological extent, and worse lung function than those in the other groups. Long-acting muscarinic antagonist/long-acting ß agonist use and mucolytics were more commonly used in the patients with post-TB bronchiectasis than those in the other groups, while inhaled corticosteroid/long-acting ß agonist was less commonly used. There were no significant intergroup differences in bronchiectasis severity scores except for FACED, the number of exacerbations, and quality of life. Post-TB bronchiectasis is characterised by reduced lung function and higher rates of mucolytic use when compared with other bronchiectasis; thus, adequate bronchodilator use and airway clearance techniques may alleviate symptom burden in this population.

show abstract

Clinical characteristics and validation of bronchiectasis severity score systems for post‐tuberculosis bronchiectasis

Abstract: There are apparent differences on radiologic features between bronchiectasis patients with and without history of pulmonary tuberculosis. Both FACED and BSI can predict mortality in post-tuberculosis bronchiectasis.

Cited by 19 publications

References 20 publications

Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis

Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis

Bronchiectasis Management in China, What We Can Learn from European Respiratory Society Guidelines

Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry

Contact Info

Product

Resources

About